Biotech
Logomix Raises 2.8 Billion Yen to Accelerate Commercialization of Cell Engineering-Based Bio Products and U.S. Expansion On July 30, 2025, Logomix Inc. announced the completion of a 2.8 billion yen (approximately $18 million USD) funding round. Logomix will use the newly raised capital to accelerate the commercialization of its multi-industry bio products, built upon its … Read More “A startup from Institute of Science Tokyo developing large-scale genome construction technology has raised funding.” »